U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07815067) titled 'A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity' on Sept. 06.

Brief Summary: The purpose of this clinical study is to test how taking zenagamtide tablets with different meal/water variations affects how much zenagamtide enters the bloodstream in people who have overweight or obesity. All participants will get zenagamtide.

Study Start Date: Sept. 07

Study Type: INTERVENTIONAL

Condition: Overweight Obesity

Intervention: DRUG: Zenagamtide injection

Zenagamtide will be administered t...